[1]
Ghosh, A.K., Palit, S. and Samajdar, S. 2017. Insilco molecular docking study of Dihydroisoquinolinium Derivatives as DPP IV Inhibitors in Type II Diabetes Mellitus. PharmaTutor. 5, 6 (Jun. 2017), 22-28.